Track the 株式会社 カイオム・バイオサイエンス stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares trade on JP JP, under the supervision of EDINET (Japan FSA). Market capitalisation: €5.4bn. The latest transaction was filed on 5 April 2024 (Holding update). Among the most active insiders: Barclays Bank PLC. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Kaiohm Bioscience is a Japanese company specializing in biotechnology. It is listed on the XTKS market.